Menu
Brighton Collaboration convenes experts around specific work areas to address the needs of the vaccine safety community. Brighton Collaboration sets up working groups to lead focused projects. View the working groups and projects below, and sort them by category.
(1 - 10 of 10)
The Safety Platform for Emergency vACcines (SPEAC) is a Brighton Collaboration project funded in whole by the Coalition for Epidemic Preparedness Innovations (CEPI).[...]
On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectives of the[...]
Rare adverse events following immunization (AEFIs) occurring in <1 per 10,000 vaccine recipients may not be detected in prelicensure clinical trials. The success[...]
Effective safety monitoring of COVID-19 vaccines must go beyond the use of passive surveillance, which is typically used to monitor vaccine safety and generate a hypothesis, to the use of active surveillance[...]
In recognition of the increasing importance of viral vectors for the development of new vaccines and the need to understand their associated safety[...]
Randomised controlled trials (RCTs) are considered the gold standard for assessing the efficacy of drugs prior to their approval for use in the[...]
Background: In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To[...]
About Immunization in PregnancyImmunization in pregnancy is a promising public health strategy to reduce illness and death among pregnant women and young infants.[...]
The Brighton Collaboration (BC) Viral Vector Vaccines Safety Working Group (V3SWG) was renamed to Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) in July[...]
Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030
